This DFE series of educational webinars looks at innovations in Oral Solid Dose Forms with the emergence of advanced technologies such as Continuous Manufacturing and 3D printing. The benefits and regulatory challenges will be explored, including how to manage the risk from the impact of excipient variability. In 3DP the conflict between the novel materials which may be required, and regulatory acceptability, is a challenge. Perceived regulatory uncertainty may limit the widespread adoption of Continuous Manufacturing, despite the benefits of no scale-up and reduced risk of segregation.
The session will be of interest to personnel in R&D, Quality, and Regulatory.
Loading your events...
Register for any/all five event(s) on October 6
In the next few minutes, you should receive a confirmation email with your login information for each event you registered for. If you do not receive a confirmation email in 15 minutes, please email support.